“ReMDO is excited to work with CCS on helping advance the field with policies such as the FDA Modernization Act of 2021 which will help usher in a new era of innovation for drug development, disease modeling, and personalized medicine using state of the art technology.”

“Current methods to develop drugs are expensive and relatively poor predictors of clinical success. With the FDA Modernization Act of 2021, there is hope to provide more human-relevant preclinical models and testing methodologies. We look forward to working with the Center for Contemporary Sciences to develop more policies that support innovative technologies such as body-on-a-chip technology platforms. This will ultimately lead to safer, less expensive therapies for our patients.”

“At BICO, we know that innovative technologies mean a future of better human health. We are proud to partner with organizations like CCS in their efforts to support the development of emerging technologies and eliminate legislative roadblocks to a healthier tomorrow.”

"The Center for Contemporary Sciences’ plan to bring together scientists, policy makers, investors, and entrepreneurs will support the transformation of biomedical sciences to develop technologies that are better for humans, and that replace animal testing.”

“I’ve been involved with many initiatives and organizations seeking to change animal-based approaches to research and toxicity testing, but Center for Contemporary Sciences is promoting an entirely new concept that I think could be the most impactful to date.”

“With the advent of ever more sophisticated human-relevant research and testing methods, it is timely that an initiative such as the Center for Contemporary Sciences should reach out to scientists and regulators in advancing this important field.”